Impact of health insurance status on prostate cancer treatment modality selection in the United States
American Journal of Clinical Oncology Oct 30, 2018
Bledsoe TJ, et al. - Among nonelderly men in the US, researchers examined whether there was an association between insurance status and prostate cancer treatment modality selection via utilizing a national data set. From 2010 to 2014, nonelderly men from 18 to 64 years of age treated for localized prostate cancer were found in the National Cancer Database. Study participants were patients with no insurance, Medicaid, or private insurance. As compared to patients with no insurance, those with private insurance were more prone to receive minimally invasive surgery and less inclined to receive external beam radiotherapy. On multivariable analysis, the strongest predictor of receiving minimally invasive surgery was private insurance, among those with no insurance and private insurance. Among nonelderly men in the US, insurance status strongly predicts of prostate cancer treatment modality.
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries